| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 196 | 1.810 | 2.601 | 4.628 | 6.106 | 0 | 0 |
| Total Income - EUR | - | - | 0 | 196 | 1.810 | 3.485 | 4.628 | 6.106 | 0 | 0 |
| Total Expenses - EUR | - | - | 6.230 | 9.952 | 10.759 | 16.005 | 9.402 | 2.788 | 4.089 | 16 |
| Gross Profit/Loss - EUR | - | - | -6.230 | -9.757 | -8.949 | -12.520 | -4.774 | 3.318 | -4.089 | -16 |
| Net Profit/Loss - EUR | - | - | -6.230 | -9.761 | -8.969 | -12.536 | -4.774 | 3.318 | -4.089 | -16 |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Genomics Evolution Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 70 | -2 | 357 | 258 | 379 | 1.679 | 1.859 | 482 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 1.493 | 1.490 | 482 |
| Cash | - | - | 70 | -2 | 357 | 258 | 379 | 186 | 370 | 0 |
| Shareholders Funds | - | - | -6.186 | -15.834 | -24.496 | -41.963 | -45.806 | -42.630 | -46.590 | -47.295 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 6.274 | 15.831 | 24.853 | 42.221 | 46.186 | 44.309 | 48.449 | 47.777 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Genomics Evolution Srl